[go: up one dir, main page]

WO2005080549A3 - Trioxacarcine et son utilisation - Google Patents

Trioxacarcine et son utilisation Download PDF

Info

Publication number
WO2005080549A3
WO2005080549A3 PCT/EP2005/001696 EP2005001696W WO2005080549A3 WO 2005080549 A3 WO2005080549 A3 WO 2005080549A3 EP 2005001696 W EP2005001696 W EP 2005001696W WO 2005080549 A3 WO2005080549 A3 WO 2005080549A3
Authority
WO
WIPO (PCT)
Prior art keywords
trioxacarcins
use against
against infections
parasites
fungi
Prior art date
Application number
PCT/EP2005/001696
Other languages
German (de)
English (en)
Other versions
WO2005080549A2 (fr
Inventor
Oliver Kayser
Hartmut Laatsch
Rajendra Prasad Maskey
Friedrich Hansske
Iris Gruen-Wollny
Elisabeth Helmke
Original Assignee
Biofrontera Discovery Gmbh
Oliver Kayser
Hartmut Laatsch
Rajendra Prasad Maskey
Friedrich Hansske
Iris Gruen-Wollny
Elisabeth Helmke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofrontera Discovery Gmbh, Oliver Kayser, Hartmut Laatsch, Rajendra Prasad Maskey, Friedrich Hansske, Iris Gruen-Wollny, Elisabeth Helmke filed Critical Biofrontera Discovery Gmbh
Publication of WO2005080549A2 publication Critical patent/WO2005080549A2/fr
Publication of WO2005080549A3 publication Critical patent/WO2005080549A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation de trioxacarcines afin de traiter des maladies infectieuses provoquées par des champignons, des parasites, des virus ou des bactéries, ainsi que de nouveaux dérivés de trioxacarcine, des médicaments contenant ces trioxacarcines ou leurs sels et l'utilisation de celles-ci afin de traiter des tumeurs, des maladies inflammatoires ou des maladies infectieuses provoquées par des champignons, des parasites, des virus ou des bactéries.
PCT/EP2005/001696 2004-02-21 2005-02-18 Trioxacarcine et son utilisation WO2005080549A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004009921 2004-02-21
DE102004009921.9 2004-02-21
DE102004017793.7 2004-04-05
DE102004017793A DE102004017793A1 (de) 2004-02-21 2004-04-05 Trioxacarcine und deren Verwendung

Publications (2)

Publication Number Publication Date
WO2005080549A2 WO2005080549A2 (fr) 2005-09-01
WO2005080549A3 true WO2005080549A3 (fr) 2005-12-08

Family

ID=34888817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/001696 WO2005080549A2 (fr) 2004-02-21 2005-02-18 Trioxacarcine et son utilisation

Country Status (2)

Country Link
DE (1) DE102004017793A1 (fr)
WO (1) WO2005080549A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI499414B (zh) 2006-09-29 2015-09-11 Lexicon Pharmaceuticals Inc 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
US7846945B2 (en) 2007-03-08 2010-12-07 Lexicon Pharmaceuticals, Inc. Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use
US9102697B2 (en) 2010-03-22 2015-08-11 President And Fellows Of Harvard College Trioxacarcins and uses thereof
WO2014082065A1 (fr) 2012-11-26 2014-05-30 President And Fellows Of Harvard College Trioxacarcines, conjugués trioxacarcine-anticorps, et leurs utilisations
WO2019036537A1 (fr) * 2017-08-17 2019-02-21 William Marsh Rice University Analogues et dimères de trioxacarcine en tant qu'agents anticancéreux puissants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071428A1 (fr) * 1981-07-22 1983-02-09 Kyowa Hakko Kogyo Kabushiki Kaisha Dérivés à activité antibiotique pouvant être obtenus à partir d'une culture de Streptomyces bottropensis
US4511560A (en) * 1979-10-26 1985-04-16 Kyowa Hakko Kogyo Kabushiki Kaisha Antibiotic substances DC-45, and their use as medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5865293A (ja) * 1981-10-13 1983-04-18 Kyowa Hakko Kogyo Co Ltd Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２からびにそれらの製造法
EP0157203A3 (fr) * 1984-04-04 1986-10-01 American Cyanamid Company Agents antitumoraux LL-D49194 alpha 1, LL-D49194 bêta 1, LL-D49194 bêta 2, LL-D49194 bêta 3, LL-D49194 gamma, LL-D49194 delta, LL-D49194 epsilon, LL-D49194 dzéta, LL-D49194 êta LL-D499194 oméga 1, LL-D49194 oméga 2 et LL-D49194 oméga 3

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511560A (en) * 1979-10-26 1985-04-16 Kyowa Hakko Kogyo Kabushiki Kaisha Antibiotic substances DC-45, and their use as medicaments
EP0071428A1 (fr) * 1981-07-22 1983-02-09 Kyowa Hakko Kogyo Kabushiki Kaisha Dérivés à activité antibiotique pouvant être obtenus à partir d'une culture de Streptomyces bottropensis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FUJIMOTO, KAZUHISA ET AL: "Antitumor activity of trioxacarcin C", JOURNAL OF ANTIBIOTICS , 36(9), 1216-21 CODEN: JANTAJ; ISSN: 0021-8820, 1983, XP008048950 *
MASKEY, RAJENDRA P. ET AL: "Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry", JOURNAL OF ANTIBIOTICS , 57(12), 771-779 CODEN: JANTAJ; ISSN: 0021-8820, 2004, XP008048955 *
TAMAOKI, TATSUYA ET AL: "Trioxacarcins, novel antitumor antibiotics. II. Isolation, physicochemical properties and mode of action", JOURNAL OF ANTIBIOTICS , 34(12), 1525-30 CODEN: JANTAJ; ISSN: 0021-8820, 1981, XP008048951 *
TOMITA, FUSAO ET AL: "Trioxacarcins, novel antitumor antibiotics. I. Producing organism, fermentation and biological activities", JOURNAL OF ANTIBIOTICS , 34(12), 1519-24 CODEN: JANTAJ; ISSN: 0021-8820, 1981, XP008048954 *

Also Published As

Publication number Publication date
WO2005080549A2 (fr) 2005-09-01
DE102004017793A1 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
CY1110230T1 (el) Αναστολεις γυρασης και χρησεις αυτων
WO2010065865A3 (fr) Agents induisant l'apoptose sélectifs pour bcl-2 pour le traitement du cancer et des maladies immunes
WO2007067559A3 (fr) Agents antibacteriens
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
WO2006102504A3 (fr) Combinaisons destinees au traitement de cancer
WO2005110994A8 (fr) Derives de pyrazolyl uree substitues utiles dans le traitement du cancer
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
WO2007077203A3 (fr) Derives de triterpenequinone et de triterpenephenol et leur application pour le traitement de tumeurs et de maladies parasitaires
WO2009026179A3 (fr) Composés de proanthocyanidine anti-infectieux et leurs procédés d'utilisation
ATE448232T1 (de) Substituierte heterozyklen
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
UA99434C2 (ru) Применение производных алкилфосфолипидов со сниженной цитотоксичностью
WO2007071658A3 (fr) Nouveaux derives d'alkylphospholipide ayant une cytotoxicite reduite et utilisations de ceux-ci
WO2007067519A3 (fr) Utilisation de neurotransmetteurs et de neuropeptides pour le traitement de maladies de secheresse oculaire et de conditions associees
HK1102702A1 (en) Anti-viral uses of borinic acid complexes
WO2010067078A8 (fr) Sels de xanthylium disubstitués en 3 et 6
WO2008082692A3 (fr) Composés d'isothiocyanate, compositions pharmaceutiques, et leurs utilisations
WO2007059226A3 (fr) Agents antimicrobiens photoactivatables
WO2007076087A3 (fr) Quinazolones d'aryle substitue et leurs utilisations
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
WO2010052575A3 (fr) Compositions à base de ngna et procédés d'utilisation
WO2009015369A3 (fr) Composés qui inhibent l'activité de la bêta-sécrétase et procédés d'utilisation de ceux-ci
WO2005080549A3 (fr) Trioxacarcine et son utilisation
WO2008001368A3 (fr) Utilisation de dérivés de stilbène pour le traitement et la prévention d'infections liées à une moisissure aquatique

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase